Medipharm Labs Corp
TSX:LABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medipharm Labs Corp
Retained Earnings
Medipharm Labs Corp
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medipharm Labs Corp
TSX:LABS
|
Retained Earnings
-CA$166m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Retained Earnings
-$9.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-13%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Retained Earnings
-CA$8.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-109%
|
|
|
Cronos Group Inc
TSX:CRON
|
Retained Earnings
$447.8m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Retained Earnings
-$532.2m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-82%
|
CAGR 10-Years
-111%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Retained Earnings
CA$148.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
Medipharm Labs Corp
Glance View
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.
See Also
What is Medipharm Labs Corp's Retained Earnings?
Retained Earnings
-166m
CAD
Based on the financial report for Dec 31, 2025, Medipharm Labs Corp's Retained Earnings amounts to -166m CAD.
What is Medipharm Labs Corp's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-23%
Over the last year, the Retained Earnings growth was -5%. The average annual Retained Earnings growth rates for Medipharm Labs Corp have been -7% over the past three years , -23% over the past five years .
